TransMedics Gr Q3 EPS $(0.78) Down From $(0.25) YoY, Sales $66.43M Beat $49.19M Estimate
Portfolio Pulse from Benzinga Newsdesk
TransMedics Gr (NASDAQ:TMDX) reported Q3 losses of $(0.78) per share, a 212% decrease YoY. However, the company's quarterly sales of $66.43M beat the analyst consensus estimate of $49.19M by 35.05%, marking a 158.65% increase YoY.
November 06, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
TransMedics Gr reported a significant YoY decrease in Q3 earnings but surpassed sales estimates.
While the company reported a significant YoY decrease in earnings, it surpassed sales estimates, which could potentially offset the negative impact of the earnings decrease on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100